Search the Newsreel

Republic Airways Holdings Inc. Announces Q2 2026 Financial Results And Increases Full Year Guidance

Republic Airways Holdings Inc. reported strong financial results for the second quarter of 2026, including revenues of $571.1 million and a net income of $31.2 million, driven by increased block hour production and the integration of Mesa Airlines. The company also raised its full-year …

Is It Too Late To Consider Buying AMREP Corporation (NYSE:AXR)?

AMREP Corporation (NYSE:AXR) saw significant share price movement recently. According to Simply Wall St's price multiple model, the stock is currently a bargain, trading below the industry average P/E ratio. However, the company is expected to deliver negative earnings growth of -1.4%, introducing some …

Republic Services (RSG) Expected to Post Quarterly Earnings on Thursday

Republic Services (RSG) is projected to release its Q2 2026 earnings on Thursday, August 6th, with analysts anticipating $1.82 EPS and $4.364 billion in revenue. The company's previous quarter surpassed expectations, and it also pays a quarterly dividend of $0.625. Wall Street currently holds …

Republic Bancorp (NASDAQ:RBCAA) Breaks Into New Territory

Replimune Group (REPL) Projected to Announce Quarterly Earnings on Thursday

Republic Airways expects Mesa merger integration to take 18-24 more months

Republic Airways Holdings Inc (RJET) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus

Ferrari eleva su guía para 2026 pese a resultados del segundo trimestre inferiores a lo esperado

Beforepay (ASX:B4P) Shares Jump After Record Margin and Profit Growth Update

PT Telkom Indonesia (Persero) Tbk Class B Revenue Breakdown – SWB:TCID

PT Telkom Indonesia (Persero) Tbk Class B (SWB:TCID) generated €7.50 billion in revenue last year. The "Business to Customer" segment was the top-performing segment, contributing €5.41 billion, while Indonesia accounted for the largest geographical contribution with €7.04 billion in revenue.

Earnings Preview: Sarepta Therapeutics (SRPT) Q2 Earnings Expected to Decline

Sarepta Therapeutics (SRPT) is expected to report a significant year-over-year decline in Q2 earnings and revenues. While analysts have recently become more bullish on the company based on a higher Most Accurate Estimate, Sarepta's Zacks Rank of #4 makes a definitive prediction of an …

Replimune Group Number of Employees 2026 | Employee Count & Headcount Data

Replimune Group, a Pharmaceuticals company founded in 2015 and headquartered in Woburn, Massachusetts, had approximately 469 employees worldwide as of March 2026, representing a 35.9% growth from 2023 but a 1.2% decline year-over-year. The company's workforce is concentrated in the United States, followed by …

Repligen Corp Q2 2026: Revenue $204.1M, EPS $0.09— 10-Q Summary

Repligen Corp (RGEN) reported its second-quarter 2026 results, with revenue increasing by 11.9% year-over-year to $204.1 million. Despite the revenue growth, net income declined to $5 million, and diluted earnings per share fell to $0.09 from $0.26 in the prior-year quarter. The company also …

Republic Services, Inc. Revenue Breakdown – DUS:RPU

Republic Services, Inc. (DUS:RPU) generated €14.13 billion in revenue last year. Its top-performing segment, Recycling and Solid Waste - Western United States, contributed €6.39 billion, a decrease from the previous year. The United States was the primary regional contributor, accounting for €13.97 billion of …

REPL: Replimune Group Inc Latest Stock Price, Analysis, News and Trading Ideas

This article provides a current overview of Replimune Group Inc. (REPL) stock, including its latest price, market performance, and financial fundamentals. It highlights recent news regarding a significant stock drop due to FDA documents and ongoing securities fraud investigations, alongside details on upcoming earnings …

REPL INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Replimune Group Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). The investigation concerns whether the Company and/or members of its senior management may have violated …

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 29, 2026--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on July 28, 2026, that were previously approved by its Board of Directors under Sarepta's 2024 Employment Commencement Incentive Plan, as amended, as …

REPUBLIC SERVICES TEAMSTERS UNANIMOUSLY AUTHORIZE STRIKE

Landfill Workers in $67 Billion Waste Giant's Backyard Fighting for Fair First Contract BUCKEYE, Ariz., July 29, 2026 /PRNewswire/ -- Republic Services workers represented by Teamsters Local 104 have unanimously voted to authorize a strike.International Brotherhood Of Teamsters The group joined the Teamsters early …

BioLife $1.5B buyout to expand Repligen Corporation (NASDAQ: RGEN) platform

Repligen Corporation reported strong Q2 2026 revenue of $204.1 million, an 11.9% increase from Q2 2025, with first-half revenue reaching $398.4 million. The company announced a definitive agreement to acquire BioLife Solutions for approximately $1.5 billion, aiming to expand its cell therapy capabilities. This …

AXR (AXR) insider plans NYSE sale of 4,000 shares under Form 144

An affiliate of AMREP Corp. (AXR) has filed a Form 144, signaling an intent to sell 4,000 common shares on the NYSE with an aggregate market value of $93,070.00. Fidelity Brokerage Services LLC is listed as the broker for this transaction. The filing indicates …

BlackRock (RSG holder) reports 4.96% beneficial stake in Republic Services (NYSE: RSG)

BlackRock has filed an amended Schedule 13G disclosing a 4.96% beneficial ownership stake in Republic Services (NYSE: RSG), amounting to 15,273,473 shares. While BlackRock holds sole voting power over 13,998,135 shares and sole dispositive power over all 15,273,473 shares, no single underlying client or …

Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up

Repligen (RGEN) reported strong second-quarter 202

Why Repligen (RGEN) Stock Is Up Today

Shares of Repligen Corporation (NASDAQ: RGEN) rose significantly after the biopharma manufacturing company reported strong second-quarter results, beating analyst expectations for both adjusted earnings and revenue. The company also raised its full-year guidance, signaling confidence in its continued performance. This positive news contrasts with …

AMREP Stock Slips Post Q4 Earnings, Net Income Declines

AMREP Corporation's stock (AXR) has fallen by 10.5% after its Q4 fiscal 2026 earnings report. While full-year revenues increased, net income for the quarter and year saw significant declines due to lower gross profit, higher tax provisions, and slower land sales, despite a strong …

Repligen Earnings: Excellent Profit Margins, China Recovery Underway

KORU Medical Systems (KRMD) Expected to Announce Quarterly Earnings on Wednesday

KORU Medical Systems (NASDAQ:KRMD) is anticipated to release its Q2 2026 earnings after the market closes on Wednesday, August 5th. Analysts project the company will report a loss of $0.02 per share and revenue of approximately $11.6 million. The company's shares opened at $4.01, …

Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier

Repligen is highlighted as a leading provider of bioprocessing solutions for biologic drug manufacturers. The company offers a range of advanced systems including filtration, fluid management, chromatography columns, and process analytics. Despite its relatively small size, Repligen is noted for its innovation and record …

Canaccord reiterates Hold on Repligen stock, keeps $145 target

Canaccord Genuity has reiterated a Hold rating on Repligen Corp. (NASDAQ:RGEN) and maintained its $145 price target, believing the shares are fairly valued. The bioprocessing company exceeded analyst expectations for its second-quarter 2026 results, reporting strong revenue growth across all franchises and raising its …

Replimune Group, Inc. SEC Filing (Jul 28, 2026)

This article announces an SEC filing (type ARS) by Replimune Group, Inc. (REPL) on July 28, 2026. The filing was accepted by the SEC on July 28, 2026, at 06:26 PM and is available as a PDF document. StockTitan provides additional context, including filing …

KORU Medical Systems Inc (KRMD) Financial Health: Profitability & Balance Sheet Analysis

KORU Medical Systems Inc (KRMD) currently holds a strong financial score of 8.14, positioning it robustly within the Healthcare Equipment & Supplies industry. This score reflects its high operating efficiency, evidenced by a 22.10% year-over-year revenue increase to $11.76M and a 30.80% rise in …

Replimune tanks on FDA concerns about its skin cancer therapy

Replimune Group Inc. (NASDAQ: REPL) saw its stock slide by over 37% after the FDA released documents raising serious questions about its skin cancer treatment, RP1, ahead of an advisory committee meeting. The FDA deemed the data package "not interpretable" due to the single-arm …

AMREP Corporation (AXR) Q2 2026 Earnings: EPS Misses Estimates but Stock Gains Amid Resilient Operations - Revenue Warning Signal

AMREP CORP. (AXR) reported fiscal year 2026 revenue of $52.847 million, a 6% increase from the previous year, despite a decline in net income to $10.288 million and diluted EPS to $1.91. The company is shifting its focus towards homebuilding, with land revenues decreasing …

Beforepay Group: Record profit and margin growth driven by higher advances and new interest-bearing products

Transcript : Frasers Centrepoint Trust, Q3 2026 Earnings Call, Jul 27, 2026

KORU Medical Systems, Inc. Revenue Breakdown – NASDAQ:KRMD

KORU Medical Systems, Inc. (NASDAQ: KRMD) generated $41.13 million USD in revenue last year. The "Domestic Core" segment was the top performer, contributing $27.99 million USD, an increase from $25.21 million USD in the prior year. The United States was the largest geographical contributor, …

REPAY Will Webcast Its Aug. 12 Fireside Chat From Boston

REPAY (NASDAQ: RPAY) announced its participation in upcoming investor conferences in August 2026. The company's CFO, Rob Houser, will host virtual investor meetings at the D.A. Davidson Virtual Small Cap Conference on August 11, and both the CEO, John Morris, and CFO will attend …